Literature DB >> 17414690

Successful monotherapy treatment with aripiprazole in a patient with schizophrenia and prolactinoma.

Bradley Freeman1, Woodburne Levy, Jack M Gorman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17414690     DOI： 10.1097/01.pra.0000265771.47153.a0

Source DB:  PubMed          Journal:  J Psychiatr Pract        ISSN： 1527-4160            Impact factor:   1.325


× No keyword cloud information.
  3 in total

1.  Treating prolactinoma and psychosis: medication and cognitive behavioural therapy.

Authors:  D H Nieman; A L Sutterland; J Otten; H E Becker; M L Drent; M van der Gaag; M Birchwood; L de Haan
Journal:  BMJ Case Rep       Date:  2011-02-09

2.  Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin).

Authors:  Deanna L Kelly; Heidi J Wehring; Amber K Earl; Kelli M Sullivan; Faith B Dickerson; Stephanie Feldman; Robert P McMahon; Robert W Buchanan; Dale Warfel; William R Keller; Bernard A Fischer; Joo-Cheol Shim
Journal:  BMC Psychiatry       Date:  2013-08-22       Impact factor: 3.630

3.  Successful treatment of a prolactinoma with the antipsychotic drug aripiprazole.

Authors:  Ilse C A Bakker; Chris D Schubart; Pierre M J Zelissen
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2016-06-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.